Owing to overexpression of the CD44 HA receptor and the receptor of hyaluronan (hyaluronic acid, HA)-mediated motility (RHAMM) on the tumor cell surface, tumor cells with high metastatic activity often exhibit increased binding and uptake of HA 190. This evidence concerns the gene HMMR and neoplasm.